FA0 Share Price Performance
€0.011
-0.02 (-58.93%)
Price €0.011
Share Price€0.011
PExA AB (publ) Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
FA0 Community Narratives
There are no narratives available yet.
Recent FA0 News & Updates
PExA AB (publ) Key Details
Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
Nov 07, 2025
- Earnings per share (EPS)
- -0.17
- Gross Margin
- 49.44%
- Net Profit Margin
- -1,203.25%
- Debt/Equity Ratio
- 0%
PExA AB (publ) Competitors
Snowflake Analysis
About FA0
- Founded
- 2004
- Employees
- 3
- CEO
- WebsiteView website
PExA AB (publ) develops and commercializes diagnostic products in various respiratory diseases. It offers its products for asthma, tuberculosis, cystic fibrosis, lung cancer, and chronic obstructive pulmonary diseases. The company’s research instrument helps lung researchers in the collection of microscopic particles and biomarkers for diseases in the small airways. It offers PExA 2.0, an instrument for the non-invasive collection of particles in exhaled air. The company also provides accessories, which include substrate surfaces and nozzles, as well as parts and service kits. It provides its products for lung research centers within the health services, academia, and pharmaceutical companies. The company was founded in 2004 and is based in Gothenburg, Sweden.
Market Insight
Q4 2025 is off to a flying start with record highs being printed left, right, and center. US and Japanese stocks made fresh new highs, while the gold price powered through $4,000 for the first time, and Bitcoin crossed the $126k level. Is this all a case of USD weakness, irrational exuberance, or solid fundamentals? This week, we are reviewing Q3 market performance, Q2 earnings season, and the outlook heading into the end of 2025…
Continue reading
Swedish Market Performance
- 7 Days: -1.1%
- 3 Months: 1.8%
- 1 Year: -1.3%
- Year to Date: 2.0%
Over the last 7 days, the market has dropped 1.1%, driven by a loss of 1.7% in the Industrials sector. Overall the market has been flat in the last year. Looking forward, earnings are forecast to grow by 16% annually. Market details ›